772 (Lansoprazole Delayed-Release (Orally Disintegrating) 30 mg)
Pill with imprint 772 is White, Round and has been identified as Lansoprazole Delayed-Release (Orally Disintegrating) 30 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Lansoprazole is used in the treatment of barrett's esophagus; duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 772
Lansoprazole Delayed-Release (Orally Disintegrating)
- Imprint
- 772
- Strength
- 30 mg
- Color
- White
- Shape
- Round
- Availability
- Rx and/or OTC
- Drug Class
- Proton pump inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 70771-1133
Related images for "772"
More about lansoprazole
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (130)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- Drug class: proton pump inhibitors
Patient resources
- Drug Information
- Lansoprazole (Advanced Reading)
- Lansoprazole Orally Disintegrating Tablets
- Lansoprazole Delayed-Release Capsules
- Lansoprazole Suspension
Other brands
Prevacid, Prevacid SoluTab, Prevacid OTC
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.